Carter Validus Mission Critical REIT II, Inc. (“CVMCR II”) announced that it acquired the Winston-Salem North Carolina Integrated Medical Facility (“IMF”) property for $6,254,000. This property, which measures approximately 22,200 square feet in net rentable area, is located in Winston-Salem, North Carolina. The facility is also within close proximity to the region’s two largest hospitals and within Forsyth County, home to North Carolina’s Biotechnology Corridor.
The facility, built in 2004, houses several specialized treatment rooms, including four auditory booths and two procedure rooms that are used for in-office surgeries and procedures. In addition, the property serves as the headquarters for Piedmont Ear, Nose & Throat Associates, PA (“PENTA”), a leading Ear, Nose and Throat (“ENT”) group in the region, which operates out of four locations in North Carolina. The property is 100% leased to PENTA.
“The IMF is designed to help ENT physicians and audiologists provide the highest level of care to their patients,” said Michael Seton, President and Chief Investment Officer, Carter Validus Advisors II, LLC. “We are pleased to align ourselves with such a well-regarded organization in the field of otolaryngology. We are thrilled to be working with high-quality tenants like PENTA and to be able to add this facility to our portfolio of mission critical assets.”
About Carter Validus Mission Critical REIT II, Inc.
Carter Validus Mission Critical REIT II, Inc. is a public, non-traded company that intends to qualify as a real estate investment trust (REIT). The REIT intends to acquire mission critical real estate assets located throughout the United States and abroad. Mission critical real estate assets are purpose-built facilities designed to support the most essential operations of tenants. Carter Validus Mission Critical REIT II, Inc. will focus its acquisitions of mission critical assets in the data centers and healthcare sectors.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of federal securities laws and regulations. These forward-looking statements are identified by their use of terms and phrases such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "predict," "project," "should," "will" and other similar terms and phrases, including references to assumptions and forecasts of future results. Forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results to differ materially from those anticipated at the time the forward-looking statements are made. Although the company believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that the expectations will be attained or that any deviation will not be material. The company undertakes no obligation to update any forward-looking statement contained herein to conform the statement to actual results or changes in the company's expectations.
